Joshua Ziel

Joshua Ziel

Company: Aerami Therapeutics

Job title: VP, Program Development

Seminars:

Inspired Products: Putting the Patient at the Center of Inhaled Therapeutic Development 10:15 am

Understanding opportunities to enhance outcomes via the inhaled route of administration Considering patient needs and context to optimize drug delivery Case studies illustrating key principles for the development of inhaled therapeuticsRead more

day: Conference Day 1

Chair’s Opening Remarks 8:50 am

Read more

day: Conference Day 1

Panel Discussion: Setting Up Context: Capitalizing on the Current Wave of Inhaled Delivery 9:00 am

With renewed interest sparked by COVID-19, unmet clinical needs and better formulation technologies, inhaled delivery offers key advantages over other routes of administration for targeted local delivery. In this panel discussion, experts will explore: Reflecting on COVID-19, renewed interest and novel technologies Formulating biologics for inhaled delivery such as mRNA Discussing advantages of inhalation to…Read more

day: Conference Day 1

Chair’s Closing Remarks 4:45 pm

Read more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.